Table 5. New-onset diabetes cases reported during whole study period.
Type of DM | Indication for rhGH treatment | Age at the baseline (years) | Age at DM diagnosis (years) | Additional risk factors | BMI (SDS) at the baseline | rhGH at the time of diagnosis | Relationship with rhGH | Action undertaken | Outcome |
---|---|---|---|---|---|---|---|---|---|
Type 2 | Idiopathic GHD | 9 | 11 | Family history (+) | 1.98 | yes | possible | none | ongoing |
Type 2 | Organic GHD | 16 | 17 | - | 2.27 | yes | not related | none | ongoing |
Type 2 | Organic GHD | 11 | 15 | - | 1.47 | yes | probable | rhGH interrupted | ongoing |
DM Diabetes mellitus, BMI body mass index, GHD growth hormone deficiency, rhGH recombinant human growth hormone